Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Development of Inhibitory Antibodies to Therapeutic Factor VIII in Severe Hemophilia A Is Associated with Microsatellite Polymorphism in the HMOX1 promoter

Yohann Repesse, PhD, Ivan Peyron, Jordan Dimitrov, PhD, Suryasarathi Dasgupta, PhD, Elika Farrokhi Moshai, Annie Borel-Derlon, MD, PhD, Catherine Costa, MD, Benoist Guillet, MD, PhD, Roseline d'Oiron, MD, Achille Aouba, MD, Chantal Rothschild, MD, Johannes Oldenburg, MD, Ana Pavlova, MD, Srinivas Kaveri, D. V. M., Ph.D, Sebastien Lacroix-Desmazes, PhD

Blood (2012) 120 (21): 38.

https://doi.org/10.1182/blood.V120.21.38.38

Published: 2012

Journal Articles

Induction of heme oxygenase-1 in factor VIII–deficient mice reduces the immune response to therapeutic factor VIII

Jordan D. Dimitrov, Suryasarathi Dasgupta, Ana-Maria Navarrete, Sandrine Delignat, Yohann Repesse, Yann Meslier, Cyril Planchais, Maud Teyssandier, Roberto Motterlini, Jagadeesh Bayry, Srinivas V. Kaveri, Sébastien Lacroix-Desmazes

Blood (2010) 115 (13): 2682–2685.

https://doi.org/10.1182/blood-2009-04-216408

Published: 2010

Includes: Supplemental data

Journal Articles

Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A

Sébastien Lacroix-Desmazes, Ana-Maria Navarrete, Sébastien André, Jagadeesh Bayry, Srinivas V. Kaveri, Suryasarathi Dasgupta

Blood (2008) 112 (2): 240–249.

https://doi.org/10.1182/blood-2008-02-124941

Published: 2008

Journal Articles

Von Willebrand Factor Protects Factor VIII from Endocytosis by Human Monocytes−Derived Dendritic Cells and Subsequent Presentation to Immune Effectors.

Yohann Repesse, Suryasarathi Dasgupta, Ana Maria Navarette, Sandrine Delignat, Bharath Wootla, Annie Borel-Derlon, Srinivas V. Kaveri, Sebastien Lacroix-Desmazes

Blood (2006) 108 (11): 761.

https://doi.org/10.1182/blood.V108.11.761.761

Published: 2006

Journal Articles

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors

Suryasarathi Dasgupta, Yohann Repessé, Jagadeesh Bayry, Ana-Maria Navarrete, Bharath Wootla, Sandrine Delignat, Theano Irinopoulou, Caroline Kamaté, Jean-Marie Saint-Remy, Marc Jacquemin, Peter J. Lenting, Annie Borel-Derlon, Srinivas V. Kaveri, Sébastien Lacroix-Desmazes

Blood (2006) 109 (2): 610–612.

https://doi.org/10.1182/blood-2006-05-022756

Published: 2006

Includes: Supplemental data

NARROW

Development of Inhibitory Antibodies to Therapeutic Factor VIII in Severe Hemophilia A Is Associated with Microsatellite Polymorphism in the HMOX1 promoter

Induction of heme oxygenase-1 in factor VIII–deficient mice reduces the immune response to therapeutic factor VIII

Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A

Von Willebrand Factor Protects Factor VIII from Endocytosis by Human Monocytes−Derived Dendritic Cells and Subsequent Presentation to Immune Effectors.

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors

Email alerts

ASH Publications

American Society of Hematology

Development of Inhibitory Antibodies to Therapeutic Factor VIII in Severe Hemophilia A Is Associated with Microsatellite Polymorphism in the HMOX1 promoter

Induction of heme oxygenase-1 in factor VIII–deficient mice reduces the immune response to therapeutic factor VIII

Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A

Von Willebrand Factor Protects Factor VIII from Endocytosis by Human Monocytes−Derived Dendritic Cells and Subsequent Presentation to Immune Effectors.

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only